USFDA classifies Sun Pharma’s Halol facility as official action indicated

By: |
Published: March 29, 2020 3:06:32 PM

The United States Food and Drug Administration (USFDA) had inspected the facility from December 03-13, 2019 and had issued eight observations, the company had earlier said in a regulatory filing in December.

USFDA, Sun Pharma, Sun Pharma Halol facility, US market, gujarat, latest news on sun pharmaSun Pharma continues to manufacture and distribute existing products for the US market, thereby not likely to have any adverse impact on current business from the facility, the drug major said.

Drug major Sun Pharmaceutical on Sunday said the US health regulator has classified its Halol facility in Gujarat as Official Action Indicated (OAI). The United States Food and Drug Administration (USFDA) had inspected the facility from December 03-13, 2019 and had issued eight observations, the company had earlier said in a regulatory filing in December.

“The company has received a communication from the USFDA indicating that the Halol facility has been classified as OAI,” Sun Pharma said in a BSE filing. The OAI classification implies inter-alia that the USFDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved, it added.

Sun Pharma continues to manufacture and distribute existing products for the US market, thereby not likely to have any adverse impact on current business from the facility, the drug major said.

“Sun Pharma continues to cooperate with the USFDA and will undertake all necessary steps to resolve these issues and to ensure that the regulator is completely satisfied with the company’s remedial action,” it added.

The company remains committed to being cGMP compliant and in supplying high-quality products to its customers and patients globally, Sun Pharma said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1UPL rating: Neutral — Synergies drove results in quarter
2HDFC rating: Buy — Earnings reflected dull realty sentiment
3RBI extends Rupee Co-op Bank licence by 3 months